Max Robotics — Global Service Robot Directory + US Certification

About

Thomas Schwarz is a pioneering researcher at the intersection of robotics and biomedical engineering, specializing in the automation of advanced therapy medicinal products (ATMPs) and tissue engineering. His work centers on developing robotic platforms to revolutionize the production of biological materials, from nanoparticles to complex 3D tissue models. Schwarz’s major contributions include establishing a flexible, modular robot-based system for automated nanoparticle manufacturing, which enhances process efficiency and product quality while simplifying human-robot interaction for non-experts. His most cited work (24 citations) demonstrates how robotic automation can significantly reduce time-consuming processes. Notably, Schwarz leads the ReBiA (Robotic Enabled Biological Automation) project, which addresses the critical shift away from animal testing—aligned with recent FDA policy changes and European Parliament initiatives—by enabling automated 3D epithelial tissue production (13 citations). He has also designed an automated platform for scaling up production of tissue-engineered cartilage products for Phase II clinical trials (13 citations), tackling the challenge of mass-producing ATMPs for unmet clinical needs. With additional work on dual-arm robotic systems for epidermal model analysis, Schwarz is at the forefront of translating lab-scale biological processes into automated, scalable manufacturing solutions.